Özet:
The aim of this study was to determine
the impact of melasma on quality of life
(QoL) using the dermatology life quality
index (DLQI) questionnaire in a group of
outpatients. This study is questionnairebased. A total of 101 Turkish women suffering from melasma, who themselves were
able to understand and complete the Turkish
version of the DLQI questionnaire, were
enrolled. This questionnaire included 10
questions; each of each was scored on a
scale of 0-3, with a maximum score of 30.
The data were analyzed after the results had
been collated and the higher the DLQI
score, the poorer the QoL. The participants’
mean age was 29.53±6.87 years, and mean
DLQI score was 6.02±4.94. When we
divided the participants into two subgroups
according to age, the DLQI scores for
younger and older individuals were
7.44±4.99 and 4.33±4.36, respectively
(P=0.001). When the melasma area and
severity index (MASI) score was used, participants with mild and moderate disease
had mean DLQI scores of 5.80±4.72 and
7.11±5.90, respectively. No patient had
severe disease. Melasma might affect the
participants’ QoL, especially that of the
younger individuals, in our study population.
